tirzepatide dosage microdose Micro-Dose Program | Weight Maintenance Tirzepatide Microdosing with Mounjaro KwikPens

Other side effects to monitor Headaches affect roughly 15 to 20 percent of GLP-1 users and are often linked to dehydration or blood sugar fluctuations

Professor Bing He from Shengjing Hospital of China Medical University explained: "GLP-1 receptor agonists were associated with a higher incidence of nausea and headache than metformin" These differences in side effect profiles play a key role in why adherence rates vary between GLP-1 therapies and metformin when used for PCOS treatment

doi: 10.1038/s41577-020-0343-0 274 The New York Times (2022)

As with any medication, it's important to discuss with a healthcare provider whether a GLP-1 receptor agonist is a suitable option for managing diabetes

Splitting your dose into two weekly injections would disrupt steady-state blood levels and likely reduce effectiveness

[] In India, the situation is particularly dire, with estimates projecting over 157 million people living with diabetes by 2050